Related Experiment Videos
Pluripotential mesenchymal cells repopulate bone marrow and retain osteogenic properties
1Department of Orthopaedic Surgery, University of Virginia School of Medicine, Charlottesville 22908, USA.
Clinical Orthopaedics and Related Research
|October 20, 2000
Summary
Multipotent bone marrow stromal cells (D1 cell line) were genetically labeled to track their osteogenic properties. These labeled cells show potential for bone repair, fracture healing, and treating osteoporosis.
Area of Science:
- Cell Biology
- Biomedical Engineering
- Regenerative Medicine
Background:
- Bone marrow stromal precursor cells possess multipotent differentiation capabilities.
- The D1 cell line exhibits osteogenic, chondrogenic, and adipogenic properties, relevant to skeletal repair.
- Osteogenic potential is crucial for fracture healing and prosthetic integration.
Purpose of the Study:
- To genetically label D1 cells for tracking osteogenic potential.
- To evaluate the in vivo and ex vivo characteristics of labeled D1 cells.
- To establish a model for studying skeletal repair and gene delivery applications.
Main Methods:
- Genetic labeling of D1 cells using a retroviral vector encoding beta-galactosidase.
- Identification of labeled cells via 5-bromo-4-chloro-3-indoyl-beta-D-galactoside staining and flow cytometry.
- Assessment of osteogenic characteristics using von Kossa staining, alkaline phosphatase assay, PTH response, osteocalcin mRNA, and in vivo diffusion chamber bone formation.
Main Results:
- Labeled D1 cells retained osteogenic characteristics in vivo and ex vivo.
- Cells repopulated host marrow, persisted, and maintained osteogenic potential.
- Demonstrated bone formation in diffusion chambers and increased cyclic adenosine monophosphate in response to PTH.
Conclusions:
- Labeled D1 cells can serve as a model for studying skeletal repair and osteoporosis treatment.
- These cells may replenish age-related decreases in osteoprogenitors, aiding bone growth and repair.
- Potential applications include fracture healing, prosthetic integration, and gene therapy for skeletal abnormalities.